Home > PS Ratio > BROOKS LABORATORIES

BROOKS LABORATORIES
PS (Price/Sales) Ratio

The Current P/S Ratio of BROOKS LABORATORIES is 4.01.

Share Price ₹129.0Apr 02,2025
Market Cap ₹380.6 Cr
Sales-TTM₹94.9 CrTTM-Consolidated Results
Price/Sales4.01xCalculated as Market Cap/Sales
Explore Stock Analytics
COMMUNITY POLL
for BROOKS LABORATORIES
Please provide your vote to see the results
BROOKS LABORATORIES is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks
Best 1M Momentum Small Cap Stocks

Definition & Calculation of PS (Price/Sales) ratio of BROOKS LABORATORIES

Price-to-Sales ratio, P/S Multiple, or P/S Ratio is an important valuation multiple that is defined as:

P/S = Market Capitalization / Sales

or, using per-share numbers:

P/S = Stock Price / Sales Per Share

Applying the above formula, P/S ratio of BROOKS LABORATORIES is calculated as :

Current Market Cap [ ₹380.6 Cr] as on Apr 02,2025

(/) Sales [ ₹94.9 Cr] based on TTM-Consolidated Results

(=) P/S Ratio [ 4.01x ]

P/S Ratio indicates 'the multiple of sales' investors are willing to pay to own one share of the company.

Thus, for BROOKS LABORATORIES , the investors are currently willing to pay '4.01 times sales' to own 1 share of the company.

PS Multiples are one of the most widely used valuation multiple in the industry.

P/S ratios can be a reliable benchmark to compare companies with negative earnings or book value.

You may also explore Price to Earnings ratio or Price to Book ratio of BROOKS LABORATORIES !

The chart below summarizes the trend in P/S Ratio of BROOKS LABORATORIES over the last five years.

Historical PS (Price/Sales) ratio chart of BROOKS LABORATORIES


PS Ratio Performance Analysis for BROOKS LABORATORIES

- BROOKS LABORATORIES 's latest p/e ratio is 4.01x.

- BROOKS LABORATORIES 's p/e ratio for fiscal years ending Mar2024 to Mar2021 averaged 2.37x.

- BROOKS LABORATORIES 's operated at median p/e ratio of 2.45x from fiscal years ending March 2018 to 2022.

- Looking back at the last 4 fiscal years, BROOKS LABORATORIES 's p/e ratio peaked in Mar2024 at 3.06x.

- BROOKS LABORATORIES 's p/e ratio hit its five-year low in Mar2022 of 1.97x.


How does BROOKS LABORATORIES 's P/S Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?

Peer Comparison (Pharmaceuticals & Drugs Industry)Sales (Cr)PS RatioMarket Cap (Cr)
BROOKS LABORATORIES 94.94.01380.6
SUN PHARMACEUTICAL INDUSTRIES LTD51,602.57.97411,306.0
DIVIS LABORATORIES LTD9,078.016.56150,343.0
CIPLA LTD26,981.24.35117,323.0
TORRENT PHARMACEUTICALS LTD11,302.09.61108,619.0
DR REDDYS LABORATORIES LTD31,229.33.0795,941.5
MANKIND PHARMA LTD11,641.08.5899,891.5
ZYDUS LIFESCIENCES LTD22,247.44.0389,680.6
LUPIN LTD22,001.64.1791,742.2
AUROBINDO PHARMA LTD30,921.82.1867,294.6
ABBOTT INDIA LTD6,243.210.0762,839.7

Pharmaceuticals & Drugs Industry Benchmark (Top 10) PS Analysis vs BROOKS LABORATORIES 's P/S Ratio

Top 10 Industry PeersPS Ratio
Min industry PS 2.18x
Max industry PS 16.56x
Median industry PS 4.35x
Average industry PS 6.78x



You may also like the below Video Courses